Anti-MAP3K13/LZK antibody
Specifications
| Product Cat#: | AB-06-2794 |
| Product type: | Primary antibody |
| Antigen: | MAP3K13/LZK |
| Immunogen: | KLH conjugated synthetic peptide derived from human MAP3K13/LZK 801-900/966 |
| Species immunized: | Rabbit |
| Isotype: | IgG |
| Applications: | Western Blot (1:500-1:1000); Immunohistochemistry-Paraffin (1:400-1:800) |
| Reactivity: | Human, Mouse, Cow, Orangutan |
| Clonality (clone number): | Polyclonal |
| Form: | Liquid |
| Buffer: | 10 mM TBS (pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| Concentration: | 1 mg/ml |
| Purity: | Protein A affinity purified |
| Storage: | Store at -20℃ for one year. Avoid repeated freeze/thaw cycles |
| Alternative names: | EC 2.7.11.25 |
| Leucine zipper bearing kinase | |
| Leucine zipper bearing kinase | |
| Leucine zipper-bearing kinase | |
| LZK | |
| M3K13_HUMAN | |
| MAP3K13 | |
| MEKK13 | |
| MGC133196 | |
| Mitogen activated protein kinase kinase kinase 13 | |
| Mitogen-activated protein kinase kinase kinase 13 | |
| Mixed lineage kinase | |
| MLK |
Show More
Target information
Activates the JUN N-terminal pathway through activation of the MAP kinase kinase MAP2K7. Acts synergistically with PRDX3 to regulate the activation of NF-kappa-B in the cytosol. This activation is kinase-dependent and involves activating the IKK complex, the IKBKB-containing complex that phosphorylates inhibitors of NF-kappa-B.
Provider
Erpantech Laboratory
